DOI: 10.1097/crd.0000000000001523 ISSN: 1061-5377

Artificial Intelligence Applied to Echocardiography for Detection of Heart Failure with Preserved Ejection Fraction and Elevated Filling Pressures: A Diagnostic Test Accuracy Meta-Analysis

Faisal A. Al-Harbi, Hatim Hussain Alawaji, Hamad Suliman Alhabdan, Norah Sulaiman Alsultan, Dana Abdullah Alrebdi, Osamah Hamdi AlMutairi, Faisal Mohammed Alharbi, Abdulmajeed Faleh Alosail

Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of heart failure cases and remains difficult to diagnose non-invasively. Artificial intelligence (AI) applied to echocardiography may improve detection, but its aggregate diagnostic accuracy has not been quantified. We performed a diagnostic test accuracy meta-analysis of AI-enabled echocardiography for identifying HFpEF, elevated left ventricular filling pressure, or diastolic dysfunction. MEDLINE/PubMed, Embase, and CENTRAL were searched from inception to June 2026. Studies reporting the accuracy of AI models applied to echocardiography against invasive, guideline-adjudicated, or ASE/EACVI reference standards were included. Sensitivity and specificity were pooled using a bivariate random-effects (Reitsma) model, with a summary receiver operating characteristic (ROC) curve, diagnostic odds ratio, and likelihood ratios. Risk of bias was assessed with QUADAS-2. Eight studies (2770 participants; 1317 [47.5%] with the target condition) were included. Pooled sensitivity was 84.0% (95% CI: 73.0–91.0%) and specificity 83.0% (95% CI: 73.0–89.0%), with an area under the summary ROC curve of 0.875 (95% CI: 0.791–0.930). The diagnostic odds ratio was 24.73 (95% CI: 18.46–33.12); positive and negative likelihood ratios were 4.84 and 0.20. Heterogeneity was high. Performance did not differ by AI architecture but varied significantly by reference standard. No small-study effects were detected. AI-enabled echocardiography shows good pooled accuracy for detecting HFpEF and elevated filling pressures, supporting its diagnostic potential. High heterogeneity and reference-standard dependence warrant larger, prospectively validated studies before routine clinical adoption.

More from our Archive